Paper36923400
The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles.
González-Rioja R and 3 others. Front Immunol, 2023. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles. Papers, record 36923400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923400
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Nanoparticles | Major topic |
| Pulmonary Surfactants | Major topic |
| Humans | |
| Surface-Active Agents | |
| RNA | |
| Tissue Distribution | |
| COVID-19 Vaccines | |
| Lipids | |
| SARS-CoV-2 | |
| Lipoproteins | |
| Liposomes |
Source PubMed
References114
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20175529 | Ion release kinetics and particle persistence in aqueous nano-silver colloids. | Environ Sci Technol | 2010 | https://conductscience.org/library/papers/20175529 | PubMed |
| 2 | 8204648 | Liposome-induced activation of the classical complement pathway does not require immunoglobulin. | Biochim Biophys Acta | 1994 | https://conductscience.org/library/papers/8204648 | PubMed |
| 3 | 28153761 | ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. | J Control Release | 2017 | https://conductscience.org/library/papers/28153761 | PubMed |
| 4 | 26929620 | Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/26929620 | PubMed |
| 5 | 20461061 | Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. | Mol Ther | 2010 | https://conductscience.org/library/papers/20461061 | PubMed |
| 6 | 35079274 | Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting. | Nano Today | 2022 | https://conductscience.org/library/papers/35079274 | PubMed |
| 7 | 20974237 | Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles. | Int J Pharm | 2011 | https://conductscience.org/library/papers/20974237 | PubMed |
| 8 | 26166403 | Rapid Synthesis of a Lipocationic Polyester Library via Ring-Opening Polymerization of Functional Valerolactones for Efficacious siRNA Delivery. | J Am Chem Soc | 2015 | https://conductscience.org/library/papers/26166403 | PubMed |
| 9 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
| 10 | 12739982 | Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12739982 | PubMed |
| 11 | 32786370 | The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/32786370 | PubMed |
| 12 | 8844203 | Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. | Hum Gene Ther | 1996 | https://conductscience.org/library/papers/8844203 | PubMed |
| 13 | 30613436 | Advances in delivery systems for doxorubicin. | J Nanomed Nanotechnol | 2018 | https://conductscience.org/library/papers/30613436 | PubMed |
| 14 | 25302857 | Nanosafety research--are we on the right track? | Angew Chem Int Ed Engl | 2014 | https://conductscience.org/library/papers/25302857 | PubMed |
| 15 | 24345865 | Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles. | Mol Ther Nucleic Acids | 2013 | https://conductscience.org/library/papers/24345865 | PubMed |
| 16 | 16862189 | Drug penetration in solid tumours. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16862189 | PubMed |
| 17 | 21500814 | Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: influence of pH, ionic strength, size, and adsorption of humic acid. | Langmuir | 2011 | https://conductscience.org/library/papers/21500814 | PubMed |
| 18 | 19895862 | Nanosystem drug targeting: Facing up to complex realities. | J Control Release | 2010 | https://conductscience.org/library/papers/19895862 | PubMed |
| 19 | 17658653 | Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. | Adv Drug Deliv Rev | 2007 | https://conductscience.org/library/papers/17658653 | PubMed |
| 20 | 27508330 | Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27508330 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41255464 | Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41255464 | PubMed |
| 39763100 | Colloid-Forming Prodrug-Hydrogel Composite Prolongs Lower Intraocular Pressure in Rodent Eyes after Subconjunctival Injection. | Adv Mater | 2025 | https://conductscience.org/library/papers/39763100 | PubMed |
| 37689341 | The RLR intrinsic antiviral system is expressed in neural retina and restricts lentiviral transduction of human Mueller cells. | Exp Eye Res | 2023 | https://conductscience.org/library/papers/37689341 | PubMed |
| 37567502 | A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/37567502 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36923400
GET https://conductscience.org/api/papers/v1/36923400/references?page=2